top of page
Yonsei's research team and CKP Therapeutics propose new treatment applied to refractory liver cancer
Bio Times - 2022.09.01 A research team in Korea has presented a new treatment strategy using SERCA inhibitors for the first time in the...
michaeljunholee
Apr 1, 20233 min read
Yonsei researchers find novel drug candidate to treat clinically refractory cancers
Korea Biomedical Review, 03.17.2023 Korean researchers said they have discovered a method to treat cancers that do not respond to...
michaeljunholee
Apr 1, 20233 min read
in the press
bottom of page